ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,585
0,48%
Bitcoin
61 751,40
-0,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bausch Health Cos (VRX)

  7. Bausch Health Cos (VRX) Actualités

VRX

Valeant Pharma (VRX)

Bausch Health Cos
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:VRX
DateHeureSourceTitreSymboleSociété
13/04/202112h58PR Newswire (Canada)Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane...NYSE:VRXBausch Health Cos
24/02/202112h59PR Newswire (US)Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 GuidanceNYSE:VRXBausch Health Cos
20/01/202113h00PR Newswire (US)Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Pr...NYSE:VRXBausch Health Cos
27/10/202011h58PR Newswire (US)Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular LensesNYSE:VRXBausch Health Cos
22/10/202013h00PR Newswire (US)Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeti...NYSE:VRXBausch Health Cos
23/09/202013h00PR Newswire (US)Bausch Health Releases Annual Corporate Social Responsibility ReportNYSE:VRXBausch Health Cos
09/09/202013h00PR Newswire (Canada)Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare ConferenceNYSE:VRXBausch Health Cos
31/07/202022h43PR Newswire (US)Bausch Health Resolves Legacy SEC InvestigationNYSE:VRXBausch Health Cos
21/05/202013h00PR Newswire (Canada)Bausch Health To Participate At Goldman Sachs Annual Global Healthcare ConferenceNYSE:VRXBausch Health Cos
29/04/202022h50PR Newswire (Canada)Bausch Health Announces 2020 Annual Meeting Of Shareholder ResultsNYSE:VRXBausch Health Cos
19/02/202022h40PR Newswire (Canada)Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of ...NYSE:VRXBausch Health Cos
03/02/202013h00PR Newswire (US)Ortho Dermatologics Opens 2020 Aspire Higher Scholarship ProgramNYSE:VRXBausch Health Cos
10/10/201913h58PR Newswire (Canada)Ortho Dermatologics Announces 2019 Aspire Higher Scholarship RecipientsNYSE:VRXBausch Health Cos
08/07/201914h00PR Newswire (US)Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6NYSE:VRXBausch Health Cos
05/12/201814h00PR Newswire (Canada)Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb Ultra® Multifocal For Astigmatism Contact LensesNYSE:VRXBausch Health Cos
30/10/201813h00PR Newswire (Canada)Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United StatesNYSE:VRXBausch Health Cos
11/10/201814h00PR Newswire (Canada)Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In Th...NYSE:VRXBausch Health Cos
16/07/201823h00Edgar (US Regulatory)Current Report Filing (8-k)NYSE:VRXBausch Health Cos
09/07/201814h00PR Newswire (Canada)Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%NYSE:VRXBausch Health Cos
03/07/201822h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:VRXBausch Health Cos
26/06/201814h00PR Newswire (US)Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)NYSE:VRXBausch Health Cos
18/06/201814h00PR Newswire (Canada)FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) LotionNYSE:VRXBausch Health Cos
14/06/201814h00PR Newswire (US)Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye DropsNYSE:VRXBausch Health Cos
12/06/201814h00PR Newswire (US)Bausch + Lomb Introduces Ocuvite® Blue Light Eye VitaminsNYSE:VRXBausch Health Cos
09/06/201800h00Business WireSecurities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Valeant Pharmaceu...NYSE:VRXBausch Health Cos
08/06/201823h15Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:VRXBausch Health Cos
01/06/201822h15PR Newswire (Canada)Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redempti...NYSE:VRXBausch Health Cos
31/05/201814h30PR Newswire (Canada)Salix To Highlight New Clinical Data During Digestive Disease WeekNYSE:VRXBausch Health Cos
23/05/201809h02Dow Jones NewsEx-Valeant Executive Convicted In Scheme -- WSJNYSE:VRXBausch Health Cos
22/05/201819h48Dow Jones NewsFormer Valeant Executive Found Guilty on Charges Related to Kickback SchemeNYSE:VRXBausch Health Cos
 Showing the most relevant articles for your search:NYSE:VRX

Dernières Valeurs Consultées

COIN
BONKOETH
BONKTOKEN [OLD]
LSE
HEDJ
Wt Eur Eq Usd H
ASX
HAL
Halo Technologies
TG
A3KT7T
Belden
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés